Evidence map›Paper›PMID 42516697›Full record

ArticleRSC pharmaceutics2026

Sequential-

Kandarp M Dave, Bodhi T Brady, Balaji Govindaswamy, Vivek S Basudkar, Donna B Stolz, Devika S Manickam

Abstract read
In one paragraph

Article in RSC pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Kandarp M DaveGraduate School of Pharmaceutical Sciences, Duquesne University Pittsburgh PA USA.ORCID https://orcid.org/0009-0009-7736-130X
Bodhi T BradyGraduate School of Pharmaceutical Sciences, Duquesne University Pittsburgh PA USA.
Balaji GovindaswamyDepartment of Neurology, The University of Texas Health Science Center 6431 Fannin Street MSE R274 Houston TX 77030 USA Devika.SoundaraManickam@uth.tmc.edu +1 (713) 500-6146.
Vivek S BasudkarGraduate School of Pharmaceutical Sciences, Duquesne University Pittsburgh PA USA.
Donna B StolzCenter for Biologic Imaging, University of Pittsburgh Medical School Pittsburgh PA USA.
Devika S ManickamDepartment of Neurology, The University of Texas Health Science Center 6431 Fannin Street MSE R274 Houston TX 77030 USA Devika.SoundaraManickam@uth.tmc.edu +1 (713) 500-6146.ORCID https://orcid.org/0000-0002-6363-3679

Funding

Engineered extracellular vesicles for the delivery of mitochondria and therapeutic proteins to the BBBR01NS136752 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Devika Soundara Manickam · 2025 to 2026
$783k
NINDS NIH HHS R01 NS136752
6 · The paper itself

Abstract

A subset of extracellular vehicles (EVs) with particle diameters >200 nm, large vesicles (lEVs), contain mitochondria that increase recipient cell bioenergetics. To date, sequential centrifugation (SC) is the most reported protocol to separate lEVs from the smaller EVs (<200 nm)/exosomes. We have previously demonstrated that lEVs derived from brain endothelial cells (BECs) using the standard SC method transfer their innate mitochondria to recipient BECs, increase recipient BEC bioenergetics, reduce brain infarct volume, and improve sensorimotor functions in a mouse model of transient ischemic stroke. Despite their promising therapeutic activity, SC-isolated lEVs are likely a mixture of mitochondria-containing lEVs and non-mitochondria-containing lEVs. We hypothesized that subsequent purification of SC-isolated lEVs using density-gradient centrifugation (DGC) may yield a purer sample of mitochondria-containing lEVs. We established a DGC protocol to purify lEVs. In this pilot study, lEVs isolated using SC and DGC protocols were compared to determine their physicochemical characteristics and their effects on recipient BEC bioenergetics. SC-lEVs and DGC-lEVs both significantly restored ATP levels in OGD-injured BECs with no difference between groups. However, a Seahorse mitochondrial function assay revealed distinct functional effects: SC-lEVs did not significantly alter respiration, whereas DGC-lEVs induced a dose-dependent increase in oxygen consumption rate, indicating enhanced oxidative phosphorylation. These findings demonstrate that DGC purification yields a more mitochondria-enriched and functionally potent lEV preparation with an enhanced capacity to restore oxidative phosphorylation in post-ischemic BECs.

Identifiers

PMID42516697
PMCPMC13404039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.